Paul Germonpré

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

Roy S. Herbst, Yan Sun, Wilfried Eberhardt et al. · The Lancet Oncology · 2010 · 417 citations · Full text

Second-line Treatment, Oncology, Metronomic Therapy +10

Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

Ronald B. Natale, David Bodkin, Ramaswamy Govindan et al. · Journal of Clinical Oncology · 2009 · 226 citations · Full text

Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.

Malcolm V. Brock, Mingzhou Gou, Yoshimitsu Akiyama et al. · PubMed · 2003 · 215 citations

Validation of Computational Fluid Dynamics in CT-based Airway Models with SPECT/CT

Jan W. De Backer, Wim Vos, Samir Vinchurkar et al. · Radiology · 2010 · 184 citations

Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation

Bart N. Lambrecht, Paul Germonpré, Els Everaert et al. · European Journal of Immunology · 1999 · 169 citations

T-regulatory Cell, Immune Regulation, Immunology +17